This sounds counterintuitive. You pay for insurance specifically to make things cheaper. But prescription drug pricing in America isn't logical — it's a labyrinth of middlemen, each taking a cut. The result: you can walk into a pharmacy, pay a $15 copay through insurance for a drug that costs $4 if you just pay cash. And the pharmacy isn't required to tell you. For the broader picture of where to find the cheapest prescriptions, see our pharmacy comparison guide.
Here's how the scam works:
This is called a "clawback" — the PBM claws back the overpayment from the pharmacy, keeping a portion for itself. You paid $15 for a $2 drug. If you'd asked for the cash price (or used Walmart's $4 program), you'd have paid $4.
A landmark 2018 study by the USC Schaeffer Center found that patients overpaid on 23% of prescription fills — paying more through insurance than the cash price. The average overpayment was $7.69 per fill. For the roughly 5.5 billion prescriptions filled annually in the U.S., that's billions of dollars in unnecessary overpayments.
The problem is worst for cheap generics. If a drug costs $3 wholesale and your copay is $10 or $15, you're guaranteed to overpay by using insurance. For expensive brand-name drugs, insurance almost always saves you money.
Here's the process to determine whether insurance or cash is cheaper for each prescription:
Before you fill, check the cash price at multiple sources:
When you drop off your prescription, ask: "Can you tell me both the insurance copay and the cash price for this medication?" Pharmacists are legally allowed to tell you the cash price — and in many states, they're now legally required to volunteer this information if the cash price is lower.
Pay whichever is cheaper — insurance or cash. You can make this decision on a per-prescription basis. Some drugs might be cheaper through insurance while others are cheaper as cash.
There's one important consideration: if you pay cash, the purchase doesn't count toward your insurance deductible or out-of-pocket maximum.
This matters if:
For most people filling cheap generics, the deductible impact is negligible. If you're paying $4 cash instead of a $15 copay, the $11 savings per fill is worth far more than the $4 that would have counted toward your deductible.
But if you take expensive brand-name medications alongside cheap generics, do the math. It may be worth overpaying on the generics to reach your deductible faster, which then reduces costs on the expensive drugs.
If you're self-employed and managing these decisions alone, CeoCult's guide on healthcare tax deductions for freelancers covers how to maximize the tax benefits of your medical spending.
These categories are where the copay-vs-cash mismatch is most common:
| Drug Category | Typical Cash Price | Typical Generic Copay | You Overpay By |
|---|---|---|---|
| Statins (atorvastatin, simvastatin) | $2-4 | $10-15 | $6-13 |
| Blood pressure (lisinopril, losartan) | $2-4 | $10-15 | $6-13 |
| Diabetes (metformin) | $3-4 | $10-15 | $6-12 |
| SSRIs (sertraline, fluoxetine) | $3-5 | $10-15 | $5-12 |
| Thyroid (levothyroxine) | $3-4 | $10-15 | $6-12 |
| Acid reflux (omeprazole) | $3-4 | $10-15 | $6-12 |
| Antibiotics (amoxicillin) | $4 | $10-15 | $6-11 |
Notice a pattern? These are all common generics that have been off-patent for years. They cost pennies to manufacture but carry inflated copays because insurance plans set copay tiers based on drug category, not actual cost.
PBMs and insurers argue that copays fund the broader insurance system and that focusing on per-drug pricing misses the big picture. They also point out that insurance-negotiated rates are lower than the pharmacy's "list price" (the highest cash price). Both points have some merit, but they don't change the fundamental math: if you can buy a drug for $4 cash, paying $15 through insurance is overpaying.
Legislative momentum is growing. Several states have passed laws requiring pharmacists to inform patients when the cash price is lower than the copay. The federal gag clause ban was a step, but enforcement remains inconsistent.
For a complete guide on all the ways to pay less, see our comprehensive guide to cheap prescriptions. And check our discount card comparison for tools that can lower your cash price even further.
Yes. Federal law (the Patient Right to Know Drug Prices Act of 2018) banned gag clauses that previously prevented pharmacists from disclosing lower cash prices. Your pharmacist can and should tell you if the cash price is lower than your copay. Simply ask: "Is the cash price lower than my copay for this drug?"
No. Cash payments bypass your insurance entirely and do not count toward your deductible or out-of-pocket maximum. For cheap generics, the savings from paying cash typically far outweigh the deductible impact. For expensive medications, using insurance may be smarter to reach your deductible faster.
PBMs are middlemen between insurance companies, pharmacies, and drug manufacturers. They negotiate drug prices, create formularies (lists of covered drugs), and process prescription claims. The three largest PBMs — CVS Caremark, Express Scripts, and OptumRx — control about 80% of the market. Critics argue they add cost without proportional value.
Weekly tips on when to use insurance vs. cash and how to cut prescription costs.